A Multicenter, Open Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of LIT-00814 Tablets in Patients With Advanced Solid Tumor/Esophageal Cancer.
Latest Information Update: 04 Mar 2024
At a glance
- Drugs LIT 00814 (Primary)
- Indications Oesophageal cancer; Solid tumours
- Focus Adverse reactions
- Sponsors LittDD Medicines
Most Recent Events
- 16 Jan 2024 New trial record